Improving the Antigenicity of sTn Antigen by Modification of Its Sialic Acid Residue for Development of Glycoconjugate Cancer Vaccines
- 26 October 2006
- journal article
- research article
- Published by American Chemical Society (ACS) in Bioconjugate Chemistry
- Vol. 17 (6), 1537-1544
- https://doi.org/10.1021/bc060103s
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Chemoenzymatically synthesized multimeric Tn/STn MUC1 glycopeptides elicit cancer-specific anti-MUC1 antibody responses and override toleranceGlycobiology, 2005
- Synthesis and Immunological Properties of N-Modified GM3 Antigens as Therapeutic Cancer VaccinesJournal of Medicinal Chemistry, 2005
- Characterization of the Metabolic Flux and Apoptotic Effects of O-Hydroxyl- and N-Acyl-modified N-Acetylmannosamine Analogs in Jurkat CellsJournal of Biological Chemistry, 2004
- Clinical outcome of breast and ovarian cancer patients treated with high-dose chemotherapy, autologous stem cell rescue and THERATOPE® STn-KLH cancer vaccineBone Marrow Transplantation, 2000
- Enhancing the Effect of THERATOPE STn-KLH Cancer Vaccine in Patients with Metastatic Breast Cancer by Pretreatment with Low-Dose Intravenous CyclophosphamideJournal of Immunotherapy, 1996
- Approaches to Augmenting the Immunogenicity of Melanoma Gangliosides: From Whole Melanoma Cells to Ganglioside‐KLH Conjugate VaccinesImmunological Reviews, 1995
- Immunization of breast cancer patients using a synthetic sialyl-Tn glycoconjugate plus Detox adjuvantCancer Immunology, Immunotherapy, 1993
- Incorporation of N‐acyl‐2‐amino‐2‐deoxy‐hexoses into glycosphingolipids of the pheochromocytoma cell line PC 12FEBS Letters, 1992
- Antigen-specific interaction between T and B cellsNature, 1985
- Quantitive estimation of sialic acidsBiochimica et Biophysica Acta, 1957